Understanding how GLP-1s affect digestion helps explain common side effects, why certain symptoms occur, and how to support your body for better results and comfort
doi:10.1111/dom.14280 Evidence-Base Disclosure The published evidence base for Semaglutide GLP-1 consists predominantly of preclinical research animal models (often rats or mice) and in vitro cell-culture experiments
By working closely with healthcare providers, patients can maximize the benefits of Semaglutide while effectively managing any risks
Methodologically akin to a retrospective cohort analysis, our study differs in that it emulates a target trial by prespecifying the protocol, aligning index date, and using propensity score matching to emulate randomization, thereby reducing immortal-time bias, improving transparency, and aligning real-world evidence generation with clinical trial standards
The best diet while on Semaglutide includes lean proteins, healthy fats, and fiber-rich foods to enhance results